pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Adynovate
drug
save

antihemophilic factor (recombinant), pegylated LA

Marketedupdated 3mo ago
by Baxalta Inc
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying antihemophilic factor (recombinant), pegylated LA

  • —A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia Aactive not recruitingn=207
  • phase3A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia Acompletedn=37
  • —ADYNOVATE Drug Use-Results Surveycompletedn=135
  • —Post Marketing Surveillance Study for ADYNOVATE in South Koreacompletedn=341

News(0)

no news has mentioned this drug yet

brand
Adynovate
generic
antihemophilic factor (recombinant), pegylated
indication
Hemophilia A (Factor VIII Deficiency)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 22m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?